Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$58,219,670
+$18,504,110 QoQ
Shares Held
737,518
+52.0% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $13,532,353,094 across 31 Diagnostics & Research names. BLLN ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,315,471 | $3,104,243,460 | |
| 2 | DHR |
Danaher Corp /De/
|
15,352,887 | $2,910,907,374 | |
| 3 | NTRA |
Natera, Inc.
|
12,184,876 | $2,436,853,350 | |
| 4 | DGX |
Quest Diagnostics Inc
|
6,297,987 | $1,234,279,491 | |
| 5 | RVTY |
Revvity, Inc.
|
10,090,158 | $883,998,742 | |
| 6 | GH |
Guardant Health, Inc.
|
7,023,689 | $648,778,152 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
305,763 | $385,628,295 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
638,063 | $358,521,218 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,219,670 | 737,518 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $39,715,560 | 485,283 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||